PharmOrgans Flashcards
CCB MOA and toxicity
-blocks voltage depedent L type calcium channels of cardiac and smooth muscle,thereby reducing muscle contractility
-verapamil, diltiazem (heart) > amlodipine, nifedipine (periph)
arteries affected more than veins
Tox: cardiac depression, AVblock, PERIPHERAL EDEMA,FLUSHING, dizziness, constipation, reflex tachycardia,
Hydralazine MOA use, toxicity
increased cGMP,causing smooth muscle relaxation. Vasodilates arterioles more than veins, decreased afterload
Severe HTN, CHF, first line for pregnany with methyldopa
Tox: compensatory tachycardia, FLUID RETENTION, LUPUS LIKE syndrome
Malignant HTN tx
nitroprusside, nicardipine, labtolol
Nitropruusside MOA/Tox
increases cGMP which increases NO, but can cause cyanide toxicity (dilates arteries and vens),
HTN drugs used in pregnancy
Hydralazine, methyldopa, labetalol, Nifedipine and CCB “HTN moms like Nifedipine”
Drugs cauing SLE like sx
Sulfonamides, hydralazine, isoniazid, procainamide, phenytoin
nitroglycerin, isosorbide, dinitrate MOA,use, tox
vasodilates by releasing NO in smooth muscle, causing increased cGMP and smooth muscle relaxation, dilates veins»_space; arteries, causing decreased preload
Use: angina, pulm edema
Tox: reflex tachy, hypoTN, flushing, heaedache
HMG-CoA reductase:
- Effect on LDL, HDL, TG
- MOA
- SE/Tox
decrease LDL XXX
increase HDL X
decrease TG X
MOA: inhibits HmG CoA to mevalonate
SE: hepatotoxicity,rhabdomyolysis
Check LFTs, CPKs
Niacin (VitB3)
- Effect on LDL, HDL, TG
- MOA
- SE/Tox
Decrease LDL XX
increased HDL XX
decrease TG X
Inhibits lipolysis in adipose tissue, reduces hepatic VLDL secretion
SE: red flushed face,rash, itching (can decrease overtime or with aspirin use)
hyperglycemia,hyperuricemia
Bile acid resins (cholestyramine, colestipol)
- Effect on LDL, HDL, TG
- MOA
- SE/Tox
Decreases LDL XX
Increases HDL ~X
Increases TG ~X
Prevents intestinal RAB of BA, liver must use cholesterol to make more
Tox: pts hate it,it tastes bad, GI discomfort, Cholesterol gallstones
Cholesteral absorbtion blockers (ezetimibe)
- Effect on LDL, HDL, TG
- MOA
- SE/Tox
LDL decreased XX
No HDL change
No TG change
Pevent cholesterol RAB at small intestine at brush border
rarely, rising LFTs and diarrhea
Fibrates
- Effect on LDL, HDL, TG
- MOA
- SE/Tox
Decrease LDL X
Increase HDL X
Decrease TG XXX
Upregulate LPL, causing increased TG clearance
Mypsitis, hepatotoxic, cholesterol gallstones
Cardiac glycosides:
MOA/Use/Toxicity
MOA: inhibits Na/K ATPase, leading to indirect inhibtion of Na/Ca exchanger, causing positive inotropy
Use fo CHF (increased contractility), atrial fibrillation (decreased condction at AV node and depresion of SA node)
Tox: cholinergic - nausea, vomitting, diarrhea, blurry YELLOW vision
EKG Changes: increased PR interval, decreased QT interval, T wave inversion, AV block, arrhthmia
can cause hyperkalemia
Mg2+ use
antiarrythmic - Use for Torsades de pointes and for digoxin toxicity
adenoseone use
antiarryhthmic which causes increased K efflux, causing hyperpolarization, so no depolarizations allowed
Drug of choice for dx/abolishing SVT
Tox: flushing, hypotension, chest pain
Antiarryhthmics - Class 1 MOA
Local anesthetic,slow or block conduction, increases effective refractory potential decreaes slope of phase 0, increases thresold for firing in abnormal pacemaker cells
HyperK causes increased toxicity for all class I drugs
Think: Double Quarter Pounder, Mayo Lettuce Tomato, Fries Please
Class IA:
Drugs, MOA,Tox
quinidine, procainamide,disopyramide
-increases AP duration, increases ERP, increases QT interval
Tox: Qunidine (cinchonism)
procainamide (reversible SLE like syndrome)
disopyramide (heart failure)
thrombocyotopenia, torsades de pointes
Class IB: Drugs, MOA,Tox
Lidocaine, mexiletine, tocainde
Decreases AP duration, preferentially affect ischemic or depolarized purkine/ventricular tissue
Useful in acute ventricular arrhyhtmias, esecially post MI
Tox: local anestheticcardiovascular depression
Class 1C: Drugs, MOA,Tox
flecainde, propafenone
MOA: used for ventricular tachcardias that rogress to VF and intractable SVT. Used only as last resort
Tox: proarrythmogenic,especially post mI (CONTRAINDICATED)
Prolons refractory period in AV node
Mechanism of action in anti arrythmics and affeceted phase?
1: Na blockers - affect p0
2: beta blockers - affect p4
3: potassium blockers - affect p3
4: CCB - affect p0
Aniarrhythmics class II Drugs, MOA, tox
Metoprolol, propanolol, esmolol, atenolol, timolol
Decrease SA and AV node by decreasing cAMP, decrease Ca currents, decreases slope 4
Tox: impotence,exacerbate asthma, may mask hypoglycemia, can exercbate vasospasm in prinzmetal angina
Antiarryhtmics class III
amiodarone, Ibutilide, Dofetilide, Sotalol
K channel blockers
Increase AP duration, increase ERP, increased QT interval
Tox:
-sotalol causes torsades de pointes
-Amiodarone: Pulm fibrosis, hepatotoxic,hypo and hyperthyroidism, corneal deposits, photodermatitis, skin deposits
Amiodarone toxicity
-Amiodarone: Pulm fibrosis, hepatotoxic,hypo and hyperthyroidism, corneal deposits, photodermatitis, skin deposits
Check LFT,TFT,and PFTs for pts on this
Class 4 Antiarrythmics
Drugs,MOA, tox
Verapamil,diltiazem
MOA:decreases conduction velocity, increases ERP, increases PR interval
Constpation, flushing, edema, torades de pointes
Propylthiouracil,methimazole MOA,Use, Toxicity
MOA: block peroxidase, thereby inhibiting organification of iodide and coupling of thyroide hormone synthesis. Also decreases periph converion of T4 to T3
Use: hyperthyroidism
Tox: skin rash, AGRANULOCYTOSIS,aplastic anema, hepatotoxicity
Levothyroxine, triiodothyronine MOA,Use, Toxicity
thyroxine replacement,which is used for hypothyroidism
tox: tachycardia,heat intolerance, tremors, arryhtmias
GH use?
GH deficiency, Turner syndrome
Somatostatin/Octreotride use?
Acromegaly,carcinoid, gastrinoma, glucagonoma (esophaeal varices)
Oxytocin
Stimulates labor,uterine contractions, milk let down, controls uterine hemorrhage
ADH/desmopressin use?
Central DI
Demeclocycline MOA, Use, Toxicity
ADH antagonist
use: SIADH
Nephrogenic DI, photosensitvity, abnl bones and teeth
Glucocoticoids
MOA, Use, Toxicity
MOA: Decrease production of leukotrienes and prostaglandins by inhibting prohpholipase A2 and expression of Cox2
use: addisons, inflammation, immune suppression, asthma
SE: Iatrogenic Cushing’s disease - buffalo hump, moon facies, truncal obesity, muscle wasting, thin skin, easy bruiseability, osteoporosis, adrenocortical atrophy, peptic ulcers, diabetes
H2 blockers (cimetidine, ranitidine, famotidine, nizatidine) MOA, Use, Toxicity
MOA: reversible block of histamine H2 receptors, causing decreased H+ production by parietal cells
Use: PUD, gastritis, GERD
Tox: Cimetidine inhibits P450, also has anti androgenic effects, can cross BBB (cause confusion,dizziness,and headaches). Cimetidine/ranitidine cause decreased Creatinine excretion by kidneys, thrombocytopenia
PPI (omeprazole, lansoprazole, esomeprazole, pantoprazole,dexlansoprazole)
MOA, Use, Toxicity
MOA: Inhibits H/K ATPase i stomach parietal cells
Use: PUD,gastritis, GERD, ZE syndrome, erosive esophagitis
Tox: increased risk for Cdiff infection, pneumonia, hip fractures, decreased serum Mg2+ after chronic use
Bismuth/Sucralfate MOA, Use, Toxicity
Binds to ulcer abse, providing protection and allowing HCO3- secretion to restablish pH gradient in mucous layer
Misoprostal MOA, Use, Toxicity
MOA: PGE1 analog,increases proxn and secretion of gastric mucous barrier, decreases acid production
Use: prevention of NSAID induced PUD, maintenance of PDA
tox: diarrhea (CONTRAINDICATED IN PREGNANT, causes abortion)
Octreotride MOA, Use, Toxicity
Somatostatin analog, used for acue variceal bleeds, VIPoma, carcinoid tumors, acromegaly
Tox: nausea, cramps, steatorrhea
Antacid toxicty for AlOH3, MgOH2, and CaCO3
AlOH3: Constipation and hypophosphotemia, prox muscle weakness, seizures, osteodystrophy
MgOH2: Diarrhea, hyporeflexia,hypoTN, cardiac arrest
CaCO3: hypercalcemia, rebound acid secretion
Osmotic laxatives (Magnesium hydroxide, magnesium citrate, polethylene glycol, lactulose) MOA, Use, Toxicity
Provide osmotic to draw water out
Use:consntipation (lactulose also for hepatic encephalopathy)
Tox: diarrhea, dehydration
Infliximab MOA, Use, Toxicity
Monoclonal Ab to TNFa
used for Chrohns disease, UC, RA
Tox: inffxn (latent TB), fever,hypoTN
Sulfasalazine MOA, Use, Toxicity
MOA: combo of antibacterial and anti inflammatory thats activated by gut bacteria
Use; CD, UC (IBD)
Tox: maliase, nausea, oligospermia, sulfonamide toxicity
Odansetron MOA, Use, Toxicity
5HT3 antagonist, central anti emetic (okay in pregnancy)
Used for psot op and chemo pts
Headahce, constipation SE
Metroclopramide MOA, Use, Toxicity
D2 receptor antagonist, causing increased resting tone, contractility, LES tone, and motility in GI.
use: Diabetic and post surg gastroparesis, antiemetic
Tox: parkinsonian effects,restlessness,drowsiness,fatigue, depression, nauesa, diarrhea
Promotility agents (Bethanechol, neostigmine, macrolides, metoclopramide)
MOA for each?
Cholingeric agent: bethanechol, neostigmine
Macrolides (eryhtromycin): increases 5HT
Metoclopramide: decreases dopamine
Heparin MOA, Indications, Toxicity
MOA: Cofactor for activation of antithrombin, causes decreased thrombin, decreased factor Xa, short half life
Use: iemdaite anticoag for PE, ACS, MI, DVT, used during pregnancy (safe in pregnancy). Follow PTT
Tox: bleeding, thrombocytopenia (HIT), osteoporsis, drug drug interactions
Note: MWH heparins (enoxaparin, dalteparin) act more on factor Xa and have better bioavailability and 2-4 times longer half life, can be administered subQ without lab monitoring.
What is HIT and what is its tx
Development of IgG ab against heparin bound to Platelet Factor 4 - these Ab-heparin-PF4 complexes activate platelets, causing thrombosis and thrombocytopenia
Bivalirudin, lepirudin
Lepirudin, bivalirduin?
Derivatives of hirudin, inhibit thrommbin (hence same job as antithrobin), used as alternative to heparin for pts with HIT
Warfarin MOA, Indications, Toxicity
MOA: intereferes with synthesis and gamma carboxyltion of Vit K dependent clotting factors II, VII, IX, X and proteins C and S. Does so by inhibiting Vit K epoxide reductase so vit K cannot activate the clotting factors
Metabolized by P450
increased PT/INR
Use: chronic anticoagulation, DVT, PE, Afib)
CONTRAINDICATED IN PREGNANCY
Tox: Bleeding, teratogenic, skin/tissue necrosis, drug-drug interactions
Direct Throbin inhibitors?
Argotraban, Dabigatran
ThrombolyticsMOA, Indications, Toxicity (tPA/alteplase, streptokinase)
MOA: Aid in conversion of plasminogen to plasmin, which cleaves thrombin and fibrin clots. Increases PT, PTT, but no change in platelets.
Use: early MI, early ischemic stroke, PE
Tox: Bleeding, many contraindications eg pts with active bleeding,intracranial bleeding, surgery, etc…
Aspirin MOA, Indications, Toxicity
MOA: Irreversibly inhibits COX1 and COX2 by covalent acetylation. Platelets cannot synthesize newenzymes so effects last until platelets die. Decreased conversion of arachidonic acids to TXA2, increased bleeding time. No change in PT or PTT
Use; Antipyretic, analgesic, anti inflammatory, anti platelet
Tox: Tinnitus (CNVIII), gastic ulceration, ARF< interstinal nepgritis, Respiratory alkalosis, Reye’s syndrome
ADP receptor inhibitor (clopidogrel, ticagrelor) MOA, Indications, Toxicity
inhibit platelet aggreagation by irrversibly blocking ADP receptors, inhibit fibrinogen binding, prevenging Gp2B3A from binding fibrinogen
Use; ACS, stening, decrease thrombotic stroke
Tox: none really
Cilastazol, dipyridamole MOA, Indications, Toxicity
Phosphodiesterase III inhibitor, increases cAMP in platelets, thus inhibiting platelet aggregation, vasodilators
Use: intermittent claudication, coronary vasodilation, prevent stroke/TIA, angina ppx
Tox: Nausea, headache, facial flushing, hypoTn, abdominal pain
GpIIbIIIa inhibitors (Abciximabb, tirofiban, eptifibatide)
Bind to Gp2b3a receptor on activatedplatelets, preventing aggregation.
Use: ACS
Tox: Bleeding, thrombocytopenia
Direct Xa inhibitors are?
Rivoroxaban, Apixaban
LMWH (Enoxaparan, Dalteparin)
Stimulate antithrombin to inactivate Xa, long t/12, subQ injection
Cancer drugs that work on: G1 Phase S Phase G2 Phase M phase
G1: none
S phase: antimetabolites, etoposide
G2: etoposide, bleomycin
M: vinca alkaloids, taxols
Common SE of cancer drugs, and why?
Diarrhea, hair loss, BM supppression –> because these cells are usuaslly rapidly dividing as well and hence are affected
Methotrexate MOA, Indications, Toxicity
Folic acid analog that inhibits dihydrofolate reductase –> decrease dTMP –> ddecreased DNA and protein synthesis
ANTIMETABOLITE
Use: leukemia, lymphomas, sarcomas, RA, psoriasis abortion, ectoic pregnancy
Tox: Myelosuppresion (reversible with leucovorin [folinic acid]). Macrovseciular fatty change in liver
Fibrotic lung dz
teratogenic
5-fluorouracil MOA, Indications, Toxicity
Pyrimidine analog bioactivated to 5F-dUMP which complexes folic acid –> inibits thymidylate synthase -> causes decreased dTMP –> decreased DNA
ANTIMETABOLITE
USed: Colon cancers, basl carcinomas, pancreatic cancers, ACTINIC KERATOSIS AS TOPICAL USE
Tox: myelosuppresion which is not reversible with leucovorin. OD can be treated with thymidine, uridine
Photosensitivity
Cytarabine MOA, Indications, Toxicity
Decreasedpyrimidine analog, which inhibits DNA polyermase
Leukemia/lymphomas
Tox: leukopenia,thrombocytopenia,megalobalstic anemiea
Azathioprine/6-MP MOA, Indications, Toxicity
Purine analog –> decreass de no purine synthesis
activated by HGPRT
Works on PRPP amidotransferase
Use: leukemia
Tox: Bone marrow, Gi, liver
Metabolized by xanthine oxidase and thus increased toxicity with allopurinol
Dactinomycin MOA, Indications, Toxicity
Intercalates in DNA
WIlms tumor, Eewings Sarcoma, Rhabdosarcoma (PEDIATRIC TUMORS)
Tox: myelosuppression
Doxorubin, daunorubicin MOA, Indications, Toxicity
generates free radicals which damage DNA and noncovalently intercaltes in DNA, reaking up DNA
-used for solid tumors, leukemias, and lymphomas
Tox: cardiotoxicity (dilated cardiomyopathy), myelosuppresion, alopecia
Dexrazoxane (used to prevent cardiotox)
Bleomycin MOA, Indications, Toxicity
induces free radical formation, which causes breaks in DNA
use in testicular cancer, hodkins lymphoma
PUlm fibrosis, skin changes
Cyclophosphamide, ifosfamide MOA, Indications, Toxicity
Covaentlyl X link DNA at guanine. Requires activation by liver
Tox: myelosuppression, HEMORRHAGIC cystitis, partially prevented with mesna, increased risk of TRANSITIONAL CELL CARCINOMA
Nitrosoureas (nitrogen mustards) - carmustine, lomustine, semustine MOA, Indications, Toxicity
requrie biactivation, cross blood brain barrier –> CNS
Glioblastoma multiforme, CNS tumors
Cns tox (diziness, ataxia possible)
Busulfan MOA, Indications, Toxicity
Alkylates DNA
CML
Tox: Pulm fibrosis,hyperpigmentation
Vincristine/Vinblastine MOA/Tox
Alkaloids that bind to tubulin in M phase and block polymerization of microtubules so mitotic spindle cannot form
Tox: vincristine: neurotoxicity (peripheral neuropathy,areflexia)
vinblastine: MYELOSUPPRESSIOn
Paclitaxel, taxols MOA/Tox
hyperstabilize polymerized microtubules in M phase so mitotic spindles cannot break down (anaphase cannot occur)
Used in ovarian and brreast carcinomas
Tox: myelosuppression and hypersensitivity
Cistplatin, carboplatin, oxaloplatin MOA/Use/Tox
Cross link DNA
Testicular, bladder, ovary, and lung carcinoma
Nephrotoxic,acoustic nerve damage,
Prevent nephrotoxicity with amifostine and chloride diuresis
Etoposide,teniposide MOA/Use/Tox
Inhibits topoisomerase II –> causeded DNA degradation
used: SCLC, prostate Ca, testocular cancer
Tox: GI irritation, alopecia, bone marrow suppression
Hydroxyurea MOA/Use/Tox
Inhibits ribonucleotide rectuase –> decrease DNA synthesis
Use: melanoma, CML, sickle cell disease
BM suppresison, GI irritability
Predisone, prednisolone MOA/Use/Tox
May trigger apoptosis
Tox: cushing like symptoms, immunosuppresion, glaucoma, cataracts, acne, osteoporosis, htn, peptic ulcer disease, hyperglycemia, psychosis
Tamoxifen/Raloxifene MOA/Use/Tox
SERMS 0 receptor antagonist in breast and agonists in bone. Blocks binding of estrogen to estrogen receptors.
Used for estrogen + breast cancer tx and prevention. Alsoused to prevent osteoporsis (raloxifene)
Tox:
Tamoxifen: partial endometrial agonist, increases risk fo endometrail cancer
Raloxifene: no endometrail agonist component, no risk